Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-SVF for Erectile Dysfunction
NCT02087397Phase 2Withdrawn
- Sponsor
- Ageless Regenerative Institute
- Start
- Mar 2014
- Primary completion
- Nov 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous adipose-derived stromal vascular fraction in erectile dysfunction (ED), sponsored by Ageless Regenerative Institute. Primary endpoint: Change from Baseline in Schramek's Grade at 6 months. Planned start Mar 2014; status: withdrawn.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02087397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087397.